Advertisement

Serous retinal detachment following non–small cell lung cancer immunotherapy

Published:January 24, 2023DOI:https://doi.org/10.1016/j.jcjo.2023.01.001
      71-year-old male was referred to the Ophthalmology Department with a choroidal metastasis shown in wide-field colour and optical coherence tomography images (A). He was found to have a primary lung adenocarcinoma, and bronchoscopic biopsies revealed tumour expression of programmed death-ligand 1. Subsequently, the immunotherapeutic agent pembrolizumab was started.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect